Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. buy tinelchen

Start price
€28.65
12.07.20 / 50%
Target price
-
17.10.20
Performance (%)
9.93%
End price
€31.50
17.10.20
Summary
This prediction ended on 17.10.20 with a price of €31.50. The BUY prediction by tinelchen finished with a performance of 9.93%. Dividends of €0.31 are taken into consideration when calculating the performance. tinelchen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Pfizer Inc. -1.216% -1.216% -34.282% -26.271%
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

According to tinelchen what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Good rating
Standard Investments for future growth
positive Cash Flow expected
Future proof or reliable business model
Known brand
Cons
Higher risks for its business
Significant cyclical dependencies

Comments by tinelchen for this prediction

In the thread Pfizer Inc. diskutieren

Buy Pfizer Inc.

In the thread Trading Pfizer Inc.
Prediction Buy
Perf. (%) 9.93%
Target price
Change
Ends at 17.10.20

Buy beendet